Clinical Trials
4 trialsNCT00098917 2008-01-28
Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00515892 2007-08-14
NHL
Cambridge Antibody Technology
Phase 1 Unknown
NCT00462189 2007-04-18
Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease
Cambridge Antibody Technology
Phase 1 Unknown
NCT00457860 2007-04-17
Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease
Cambridge Antibody Technology
Phase 1 Unknown